首页> 外文OA文献 >Pharmacological evaluation of NF279 as a P2 receptor antagonist : structure-activity relationship studies of analogues of the P2 receptor antagonists Suramin and NF023 at native P2 receptor subtypes and ecto-nucleotidases

【2h】

Pharmacological evaluation of NF279 as a P2 receptor antagonist : structure-activity relationship studies of analogues of the P2 receptor antagonists Suramin and NF023 at native P2 receptor subtypes and ecto-nucleotidases

机译：NF279作为P2受体拮抗剂的药理评价：天然P2受体亚型和胞外核苷酸酶类P2受体拮抗剂Suramin和NF023类似物的构效关系研究

页面导航

著录项
相似文献
相关主题

著录项

作者
Damer Susanne;
展开▼
作者单位

展开▼
年度 2003
总页数
原文格式 PDF
正文语种 {"code":"en","name":"English","id":9}
中图分类

相似文献

外文文献
中文文献
专利

1. Structure-activity relationships of suramin and pyridoxal-5'-phosphate derivatives as P2 receptor antagonists. [J] . Lambrecht G, Braun K, Damer M, Current pharmaceutical design . 2002,第26期

机译：苏拉明和吡ido醛-5'-磷酸衍生物作为P2受体拮抗剂的构效关系。
2. Minor contribution of ATP P2 receptors to electrically-evoked electrographic seizure activity in hippocampal slices: Evidence from purine biosensors and P2 receptor agonists and antagonists. [J] . Lopatar J, Dale N, Frenguelli BG Neuropharmacology . 2011,第1a2期

机译：ATP P2受体对海马脑片电诱发的癫痫发作活动的微小贡献：嘌呤生物传感器和P2受体激动剂和拮抗剂的证据。
3. Antagonistic properties of the suramin analogue NF023 at heterologously expressed P2X receptors. [J] . Soto F, Lambrecht G, Nickel P, Neuropharmacology . 1999,第1期

机译：苏拉明类似物NF023在异源表达的P2X受体上的拮抗特性。
4. Agonists and antagonists for P2 receptors [C] . Kenneth A. Jacobson, Stefano Costanzi, Bhalchandra V. Joshi, Symposium on Purinergic Signalling in Neuron-Glia Interactions . 2006

机译：P2受体的激动剂和拮抗剂
5. A structure-activity approach to drug action in pharmacology: (A) Structure-activity relationships involved in DT-diaphorase (NQO1) mediated reduction kinetics and mode of action of anticancer bioreductive benzoquinone alkylating agents. (B) Structural characteristics of novel NMDA receptor antagonists required for renal tubule organic cation secretion . [D] . Fourie, Jeanne. 2004

机译：一种在药理学中用于药物作用的结构活性方法：（A）DT-黄递酶（NQO1）介导的抗癌生物还原苯醌烷基化剂的还原动力学和作用方式的结构活性关系。（B）肾小管有机阳离子分泌所需的新型NMDA受体拮抗剂的结构特征。
6. Synthesis and Structure-Activity Relationships of Pyridoxal-6-arylazo-5′-phosphate and Phosphonate Derivatives as P2 Receptor Antagonists [O] . Yong-Chul Kim, Emidio Camaioni, Airat U. Ziganshin, -1

机译：Pyridoxal-6-芳基偶氮-5-磷酸盐和膦酸酯衍生物作为P2受体拮抗剂的合成及构效关系
7. Synthesis and Structure-Activity Relationships of Pyridoxal-6-arylazo-5'-phosphate and Phosphonate Derivatives as P2 Receptor Antagonists. [O] . Kim Yong-Chul, Camaioni Emidio, Ziganshin Airat U., 1998

机译：吡咯醛-6-芳基偶氮-5'-磷酸盐和膦酸酯衍生物作为P2受体拮抗剂的合成及构效关系。

Pharmacological evaluation of NF279 as a P2 receptor antagonist : structure-activity relationship studies of analogues of the P2 receptor antagonists Suramin and NF023 at native P2 receptor subtypes and ecto-nucleotidases

著录项

相似文献

相关主题

期刊订阅